Viseon Spine Closes $5 Million Series A Financing

Viseon Spine Incorporated

Represented Viseon Spine Incorporated in connection with the closing of its $5 million Series A financing, led by HBM-MedFocus, Invus Opportunities Fund, and affiliates of Wexford Capital LP. The money raised will be used to support product development, worldwide regulatory approvals, clinical evaluations and initial manufacturing scale-up and commercialization efforts. Read the press release.

Founded in early 2017 as a spin-off of Stradling client Rebound Therapeutics Corporation, Viseon Spine is an Irvine-based medical device company that uses its proprietary technology comprised of state-of-the-art visualization and illumination technologies to develop single use and disposable devices that improve the procedural and clinical outcomes of minimally invasive spine surgery procedures.

The Newport Beach-based deal team representing Viseon Spine included Jeff EstesLarry Cohn and Arash Lessantiz.